240 related articles for article (PubMed ID: 32958211)
1. Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for neuroprotection.
Saccà SC; Vernazza S; Iorio EL; Tirendi S; Bassi AM; Gandolfi S; Izzotti A
Prog Brain Res; 2020; 256(1):151-188. PubMed ID: 32958211
[TBL] [Abstract][Full Text] [Related]
2. From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma.
Saccà SC; Gandolfi S; Bagnis A; Manni G; Damonte G; Traverso CE; Izzotti A
Ageing Res Rev; 2016 Aug; 29():26-41. PubMed ID: 27242026
[TBL] [Abstract][Full Text] [Related]
3. Substances of Interest That Support Glaucoma Therapy.
Saccà SC; Corazza P; Gandolfi S; Ferrari D; Sukkar S; Iorio EL; Traverso CE
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678262
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondria in the pathogenesis and treatment of glaucoma.
Yang XJ; Ge J; Zhuo YH
Chin Med J (Engl); 2013 Nov; 126(22):4358-65. PubMed ID: 24238529
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
Babizhayev MA
Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
[TBL] [Abstract][Full Text] [Related]
6. Functional morphology of the trabecular meshwork in primate eyes.
Lütjen-Drecoll E
Prog Retin Eye Res; 1999 Jan; 18(1):91-119. PubMed ID: 9920500
[TBL] [Abstract][Full Text] [Related]
7. Estrogen dysregulation, intraocular pressure, and glaucoma risk.
Youngblood H; Schoenlein PV; Pasquale LR; Stamer WD; Liu Y
Exp Eye Res; 2023 Dec; 237():109725. PubMed ID: 37956940
[TBL] [Abstract][Full Text] [Related]
8. Glaucomatous cell derived matrices differentially modulate non-glaucomatous trabecular meshwork cellular behavior.
Raghunathan VK; Benoit J; Kasetti R; Zode G; Salemi M; Phinney BS; Keller KE; Staverosky JA; Murphy CJ; Acott T; Vranka J
Acta Biomater; 2018 Apr; 71():444-459. PubMed ID: 29524673
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis in Glaucoma: A Promising Avenue for Therapy.
Zhu J; Chen H; Wu J; Li S; Lin W; Wang N; Bai L
Adv Biol (Weinh); 2024 May; 8(5):e2300530. PubMed ID: 38411382
[TBL] [Abstract][Full Text] [Related]
10. Trabecular meshwork as a new target for the treatment of glaucoma.
Ferrer E
Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JP; Nash MS
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S102-28. PubMed ID: 10416754
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review.
Wang M; Li J; Zheng Y
Med Sci Monit; 2020 Jan; 26():e921514. PubMed ID: 31949124
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease 5 coordinates signals for the regulation of intraocular pressure and inhibits neural apoptosis as a novel multi-functional anti-glaucomatous strategy.
Kim KW; Park SH; Oh DH; Lee SH; Lim KS; Joo K; Chun YS; Chang SI; Min KM; Kim JC
Biochim Biophys Acta; 2016 Feb; 1862(2):145-54. PubMed ID: 26581172
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.
Vranka JA; Kelley MJ; Acott TS; Keller KE
Exp Eye Res; 2015 Apr; 133():112-25. PubMed ID: 25819459
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Strategies in Glaucoma.
Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
[TBL] [Abstract][Full Text] [Related]
16. Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork.
Bhattacharya SK; Rockwood EJ; Smith SD; Bonilha VL; Crabb JS; Kuchtey RW; Robertson NG; Peachey NS; Morton CC; Crabb JW
J Biol Chem; 2005 Feb; 280(7):6080-4. PubMed ID: 15579465
[TBL] [Abstract][Full Text] [Related]
17. A 3D Model of Human Trabecular Meshwork for the Research Study of Glaucoma.
Tirendi S; Saccà SC; Vernazza S; Traverso C; Bassi AM; Izzotti A
Front Neurol; 2020; 11():591776. PubMed ID: 33335510
[TBL] [Abstract][Full Text] [Related]
18. Future possibilities in glaucoma therapy.
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Med Sci Monit; 2010 Nov; 16(11):RA252-9. PubMed ID: 20980972
[TBL] [Abstract][Full Text] [Related]
19. The dysfunction of the trabecular meshwork during glaucoma course.
Saccà SC; Pulliero A; Izzotti A
J Cell Physiol; 2015 Mar; 230(3):510-25. PubMed ID: 25216121
[TBL] [Abstract][Full Text] [Related]
20. Senescent phenotype of trabecular meshwork cells displays biomarkers in primary open-angle glaucoma.
Babizhayev MA; Yegorov YE
Curr Mol Med; 2011 Oct; 11(7):528-52. PubMed ID: 21707516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
